Hepatocellular Carcinomas

Top PDF Hepatocellular Carcinomas:

Immunohistochemical analysis of metastasising hepatocellular carcinomas in dogs

Immunohistochemical analysis of metastasising hepatocellular carcinomas in dogs

We used MCM3 to assess the proliferative poten- tial and the degree of malignancy of the tumour and its metastases. MCM3 staining was strong in the nuclei of cells. This protein is part of the minichro- mosomal maintenance complex that plays a key role in DNA replication during S phase (Musahl et al. 1998; Endl et al. 2001; Nowak et al. 2008). Our results may indicate a high grade of malignancy of the studied hepatocellular carcinomas. The fast and infiltrative tumour growth and the presence of metastases in the studied organs, which also Table 1. Comparison of the results of the immunohisto-
Show more

7 Read more

Met regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

Met regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

Identification of specific gene expression signatures characteristic of oncogenic pathways is an important step toward molecular classification of human malignancies. Aberrant activation of the Met signaling pathway is frequently associated with tumor progression and metastasis. In this study, we defined the Met-dependent gene expression signature using global gene expression profiling of WT and Met-deficient primary mouse hepatocytes. Newly identified transcriptional targets of the Met pathway included genes involved in the regula- tion of oxidative stress responses as well as cell motility, cytoskeletal organization, and angiogenesis. To assess the importance of a Met-regulated gene expression signature, a comparative functional genomic approach was applied to 242 human hepatocellular carcinomas (HCCs) and 7 metastatic liver lesions. Cluster analysis revealed that a subset of human HCCs and all liver metastases shared the Met-induced expression signature. Furthermore, the presence of the Met signature showed significant correlation with increased vascular inva- sion rate and microvessel density as well as with decreased mean survival time of HCC patients. We conclude that the genetically defined gene expression signatures in combination with comparative functional genom- ics constitute an attractive paradigm for defining both the function of oncogenic pathways and the clinically relevant subgroups of human cancers.
Show more

15 Read more

Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome

Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome

Discrimination of Hepatitis C Virus in Liver Tissues from Different Patients with Hepatocellular Carcinomas by Direct Nucleotide Sequencing of Amplified cDNA of the Viral Genome WEN-HSIA[r]

5 Read more

Original Article Down-expression of homeobox A9promotes cancer cell invasion in human hepatocellular carcinomas

Original Article Down-expression of homeobox A9promotes cancer cell invasion in human hepatocellular carcinomas

Abstract: Metastasis is the most important contributor to the mortality ofpatients with hepatocellular carcinomas (HCCs), but the molecular basis for this is unknown. Previous studies had found that homeobox A9 (HOXA9) wasfre- quently methylated in HCCs; however, little is known about whether HOXA9 can influence the malignant properties of HCC cells and the exhaustive mechanisms in HCC progression. In a screen of 82 patients with HCCs, we found that HOXA9 protein expression was inversely correlated with invasion, lymphnode metastasis, and poor clinical out- comes. Silencing HOXA9 in HCC cells increased their neoplastic properties invitro and in vivo, markedly increasing the migratory, invasive, and metastatic capabilities of malignant cells. In contrast, ectopic expression of HOXA9 in HCC cells inhibited these processes. We also found that HOXA9 promoted the expression of E-cadherin and inhibited the expression of N-cadherin. These observations contribute to our understanding of the important roles of HOXA9 in HCC development and progression and HOXA9 could be a promising molecular target for the development of new diagnostic and therapeutic strategies for HCC.
Show more

13 Read more

The Role of Diffusion Weighted Magnetic Resonance Imaging in the Differential Diagnosis of Hepatocellular Carcinomas and Regenerative-Dysplastic Nodules in Cirrhotic Liver

The Role of Diffusion Weighted Magnetic Resonance Imaging in the Differential Diagnosis of Hepatocellular Carcinomas and Regenerative- Dysplastic Nodules in Cirrhotic Liver

up images (18-27 months, mean 19.2 months follow up time). Magnetic resonance images along with Diffusion weighted images with b = 800 s/mm 2 were evaluated by 2 radiologists. All imaging examinations were performed with 1.5 Tesla MR machine. Diffusion weighted images and ADC (apparent diffusion coefficient) mapping of lesions were evaluated and ADC values were calculated. The results were compared with conventional dynamic magnetic resonance images. Results: In our study 95% of 40 Hepatocellular carcinomas demonstrated diffusion restriction. 52% of 25 RDN were isointense on diffusion-weighted images. The difference of the signal intensity distribution was statistically significant between two lesions (p<0.001). On quantitative analysis, we calculated ADC values of lesions and ADC ratio of lesion-to-liver values. The mean ADC values and ADC ratio of the RDN was higher than that of the hepatocellular carcinomas, and there was a significant difference between 2 groups (p<0.001). When a cutoff value of 0.95 is considered for ADC ratio, on diffusion imaging with ADC mapping 97.5% sensitivity and 64% specificity can be calculated to differentiate hepatocellular carcinoma from RDN.
Show more

9 Read more

Expression and biological significance of c-FLIP in human hepatocellular carcinomas

Expression and biological significance of c-FLIP in human hepatocellular carcinomas

Human HCC (hepatocellular carcinomas) is the common hepatic highly malignant tumor. Most patients, especially in China, present at diagnosis with a high stage. The etio- pathogenisis and developments of HCC are not well known. Deregulation of cell proliferation and cell apopto- sis underlies neoplastic initiation and development, which involves multiple gene alterations, and is regulated by complicated signal transduction pathways. It has become clear that deregulated apoptosis plays a pivotal role in tumorigenesis, malignancy and metastatic poten- tial [1].

8 Read more

Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican 3 in hepatocellular carcinomas

Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican 3 in hepatocellular carcinomas

Liver cancer is the leading cause of cancer death world- wide and is the second leading cause of cancer death in men [1]. As hepatocellular carcinoma (HCC) is the most common liver malignancy, the molecular mechanism of its malignant phenotype has been a focus of intensive investigation. We previously reported the identification of prognostic factors for HCC, including glypican-3 (GPC3) [2, 3] and monocarboxylate transporter 4 (MCT4) [4]. GPC3 is an oncofetal glycoprotein connected to the cell membrane via a glycosylphosphatidylinositol anchor [5] and regulates some signaling activities including canonical Wnt signaling [6]. GPC3 is highly expressed
Show more

7 Read more

Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas

Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas

Cancer metastasis is a complex process, and the incidence of metastasis is influenced by many biological factors. Orosomucoid 2 (ORM2) is an important glycoprotein that is mainly biosynthesized and secreted by hepatocytes. As an acute-phase protein, ORM2 likely plays important roles in anti-inflammation, immunomodulation and drug delivery. However, little is known regarding the function of ORM2 in hepatocellular carcinoma (HCC). In this study, we determined that ORM2 expression in HCC tissues was negatively associated with intrahepatic metastasis and histological grade. Moreover, the ectopic overexpression of ORM2 decreased HCC cell migration and invasion in vitro and intrahepatic metastasis in vivo, whereas silencing ORM2 expression resulted in increased tumor cell migration and invasion in vitro. The CCAAT/enhancer binding protein β (C/EBPβ) upregulated ORM2 expression, while only the LAP1/2 (C/EBPβ isoforms) possessed transcription-promoting activity on the ORM2 promoter. Subsequently, we found that LAP1 repressed HCC cell migration and invasion via the induction of ORM2 expression. Consistently, the protein expression of C/EBPβ was negatively associated with histological grade and positively correlated with ORM2 protein expression in HCC tissues. Collectively, our findings indicate that ORM2 is a functional downstream target of C/EBPβ and functions as a tumor suppressor in HCC.
Show more

14 Read more

Virus induced hepatocellular carcinomas cause antigen specific local tolerance

Virus induced hepatocellular carcinomas cause antigen specific local tolerance

T cell surveillance is often effective against virus-associated tumors because of their high immunogenicity. It is not clear why surveillance occasionally fails, particularly against hepatitis B virus– or hepatitis C virus–asso- ciated hepatocellular carcinoma (HCC). We established a transgenic murine model of virus-induced HCC by hepatocyte-specific adenovirus-induced activation of the oncogenic SV40 large T antigen (TAg). Adenovirus infection induced cytotoxic T lymphocytes (CTLs) targeted against the virus and TAg, leading to clearance of the infected cells. Despite the presence of functional, antigen-specific T cells, a few virus-infected cells escaped immune clearance and progressed to HCC. These cells expressed TAg at levels similar to HCC isolated from neonatal TAg-tolerant mice, suggesting that CTL clearance does not select for cells with low immunogenicity. Virus-infected mice revealed significantly greater T cell infiltration in early-stage HCC compared with that in late-stage HCC, demonstrating progressive local immune suppression through inefficient T cell infiltration. Programmed cell death protein-1 (PD-1) and its ligand PD-L1 were expressed in all TAg-specific CD8 + T cells
Show more

13 Read more

A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies

A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies

Hepatocellular carcinoma (HCC) is one of the most fre- quently occurring malignant tumors worldwide [1]. Risk factors of HCC are well recognized including gender, infection by hepatitis B virus or hepatitis C virus, cirrhosis, metabolism diseases, toxins, excess alcohol consumption, and smoking. HCC varies with wide geography, and is more prevalent in Asia, Africa, and southern Europe. It has been well defined that experiencing surgery for early HCC patients could achieve a higher curative resection

10 Read more

Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases

Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases

Morgan B, Thomas AL, Drevs J, et al : Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascul[r]

7 Read more

High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study

High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study

21. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, Lai CL: Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008, 57:98-102.

5 Read more

Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Matsubara, Genes Develop., in press, we analyzed the structures of 19 virus genomes integrated in chromosomes of human hepatomas and showed that in about half of the studied cases, the v[r]

7 Read more

Use of a New Algorithm with an Internally Cooled Electrode for Radiofrequency Ablation of Small Hepatocellular Carcinomas

Use of a New Algorithm with an Internally Cooled Electrode for Radiofrequency Ablation of Small Hepatocellular Carcinomas

Patients were included following institutional review board approval. Informed consent was waived in this retrospective analysis. Exclusion criteria were: (1) pres- ence of tumors >3 cm in average diameter, (2) extra- hepatic disease, (3) tumor invasion into the main or lobar portal vein. Diagnosis of HCC, as shown on CT or Mag- netic Resonance Imaging (MRI), was based on arterial hypervascularity in a lesion >1 cm with venous or de- layed phase washout in accordance with American Asso- ciation for the Study of Liver Diseases (AASLD), which takes the view that a lesion found incidentally or on screening in a patient with known hepatitis B or cirrhosis of other etiology is likely to be hepatocellular carcinoma [10].
Show more

5 Read more

Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion

Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion

We also performed an in vitro experiment to validate the effect of Abl2 gene silencing on the migration and invasion abilities of human liver cancer HepG2 cells.. Results: It has been [r]

5 Read more

Analysis of integrated ground squirrel hepatitis virus and flanking host DNA in two hepatocellular carcinomas.

Analysis of integrated ground squirrel hepatitis virus and flanking host DNA in two hepatocellular carcinomas.

The left end of RV50 integrated DNA is located 4 bp 5291 Downloaded from http://jvi.asm.org/ on November 9, 2019 by guest We cloned the integrated ground squirrel hepatitis B virus GSHV [r]

5 Read more

Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas

Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas

Box-plot diagrams were analyzed to compare hypermethylated genes ( CLCN1 , GRASP and TSPYL5 ) under-expressed in HCC tumor tissue, and that display no significant losses of CNV compared [r]

12 Read more

Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas

Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas

In addition, we identified that shared muta- tions between primary tumors and metastases were sig- nificantly enriched in the pathways of bladder cancer, pancreatic cancer, non-small cel[r]

13 Read more

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response

Abstract: Autophagy is an intracellular lysosomal degradation process performed by the cells to maintain energy balance. The autophagy response plays an important role in the progression of liver disease due to hepatitis virus infection, alcoholic liver disease, nonalcoholic fatty liver disease, liver cirrhosis, and hepatocellular carcinoma (HCC). An increased autophagy response also contributes to the pathogenesis of liver disease through modulation of innate and adaptive immune responses; a defective cellular autophagy response leads to the development of HCC. Recent progress in the field indicates that autophagy modulation provides a novel targeted therapy for human liver cancer. The purpose of this review is to update our understanding of how the cellular autophagy response impacts the pathophysiology of liver disease and HCC treatment. Keywords: hepatocellular carcinoma, macroautophagy, microautophagy, autophagy inhibitor, chloroquine, hydroxychloroquine, sorafenib
Show more

12 Read more

High Expression of H3K27me3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients

High Expression of H3K27me3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients

With regard to the prognostic impact of H3K27me3 in different human can- cers, some of the reported data are to- tally contradictory. It was documented that loss expression of H3K27me3 was linked to poor prognosis of patients with breast, ovarian and pancreatic cancers (16). In esophageal carcinomas, however, we and other groups found that high ex- pression of H3K27me3 was positively as- sociated with high invasiveness and/or poor survival (18). Considering that the mechanism by which EZH2-mediated H3K27 methylation leads to gene silenc- ing may vary among gene targets and among organisms (36), it is not very hard for us to understand that the function of Figure 5. ROC curve analysis for different clinicopathological features and H3K27me3 expression was performed to evaluate the survival status. (A) Sex (AUC = 0.539; P = 0.339), age (AUC = 0.504; P = 0.923), serum AFP (AUC = 0.678; P < 0.0001), hepatitis history (AUC = 0.510; P = 0.812), cirrhosis (AUC = 0.503; P = 0.942), tumor multiplicity (AUC = 0.687; P < 0.0001), tumor size (AUC = 0.699; P < 0.0001), differentiation (AUC = 0.597; P = 0.017) stage (AUC = 0.746; P < 0.0001), H3K27me3 expression (AUC = 0.733; P < 0.0001), vascular invasion (AUC = 0.764; P < 0.0001), and relapse (AUC = 0.664; P < 0.0001) implied statistical associations with survival in the testing cohort. (B) Sex (AUC = 0.508; P = 0.880), age (AUC = 0.521; P = 0.695), serum AFP (AUC = 0.702; P < 0.0001), hepatitis history (AUC = 0.504; P = 0.940), cirrhosis (AUC = 0.491; P = 0.868), tumor multiplicity (AUC = 0.710; P < 0.0001), tumor size (AUC = 0.715; P = 0.002), differentiation (AUC = 0.612; P = 0.036) stage (AUC = 0.761; P < 0.0001), H3K27me3 expression (AUC = 0.719; P < 0.0001), vascular invasion (AUC = 0.757; P < 0.0001) and relapse (AUC = 0.712; P < 0.0001) were used to test the survival status in validation cohort.
Show more

9 Read more

Show all 3874 documents...